Klasen IS - Search Results

1

Antibodies against the CUB1-2 domains of ADAMTS13 in a patient with benign monoclonal gammopathy: no causal relationship.

Riksen NP, Luken BM, Klasen IS, Voorberg J, Crama N, van Deuren M. Riksen NP, et al. Among authors: klasen is. Haematologica. 2007 Jul;92(7):e74-6. doi: 10.3324/haematol.11475. Haematologica. 2007. PMID: 17650455 Free article.

2

Complement activation in experimental human malaria infection.

Roestenberg M, McCall M, Mollnes TE, van Deuren M, Sprong T, Klasen I, Hermsen CC, Sauerwein RW, van der Ven A. Roestenberg M, et al. Trans R Soc Trop Med Hyg. 2007 Jul;101(7):643-9. doi: 10.1016/j.trstmh.2007.02.023. Epub 2007 May 3. Trans R Soc Trop Med Hyg. 2007. PMID: 17481680

3

The complement system is activated in a biphasic pattern after coronary artery bypass grafting.

Hoedemaekers C, van Deuren M, Sprong T, Pickkers P, Mollnes TE, Klasen I, van der Hoeven J. Hoedemaekers C, et al. Ann Thorac Surg. 2010 Mar;89(3):710-6. doi: 10.1016/j.athoracsur.2009.11.049. Ann Thorac Surg. 2010. PMID: 20172115

4

Development of immunoglobulin A in infancy and childhood.

Weemaes C, Klasen I, Göertz J, Beldhuis-Valkis M, Olafsson O, Haraldsson A. Weemaes C, et al. Scand J Immunol. 2003 Dec;58(6):642-8. doi: 10.1111/j.1365-3083.2003.01344.x. Scand J Immunol. 2003. PMID: 14636420 Free article.

5

Detecting only light chains, now what?

Jacobs JF, Joosten I, Klasen IS. Jacobs JF, et al. Among authors: klasen is. Clin Chem. 2010 Aug;56(8):1368. doi: 10.1373/clinchem.2010.148494. Clin Chem. 2010. PMID: 20668174 No abstract available.

6

Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients.

Jacobs JF, Punt CJ, Lesterhuis WJ, Sutmuller RP, Brouwer HM, Scharenborg NM, Klasen IS, Hilbrands LB, Figdor CG, de Vries IJ, Adema GJ. Jacobs JF, et al. Among authors: klasen is. Clin Cancer Res. 2010 Oct 15;16(20):5067-78. doi: 10.1158/1078-0432.CCR-10-1757. Epub 2010 Aug 24. Clin Cancer Res. 2010. PMID: 20736326 Clinical Trial.

7

Decreased renal excretion of soluble interleukin-2 receptor alpha after treatment with daclizumab.

ter Meulen CG, Göertz JH, Klasen IS, Verweij CM, Hilbrands LB, Wetzels JF, Hoitsma AJ. ter Meulen CG, et al. Among authors: klasen is. Kidney Int. 2003 Aug;64(2):697-703. doi: 10.1046/j.1523-1755.2003.00116.x. Kidney Int. 2003. PMID: 12846768 Free article. Clinical Trial.

8

Hyper-immunoglobulin A in the hyperimmunoglobulinemia D syndrome.

Klasen IS, Göertz JH, van de Wiel GA, Weemaes CM, van der Meer JW, Drenth JP. Klasen IS, et al. Clin Diagn Lab Immunol. 2001 Jan;8(1):58-61. doi: 10.1128/CDLI.8.1.58-61.2001. Clin Diagn Lab Immunol. 2001. PMID: 11139196 Free PMC article.

9

The fractional excretion of soluble interleukin-2 receptor-alpha is an excellent predictor of the interleukin-2 receptor-alpha status after treatment with daclizumab.

ter Meulen CG, Jacobs CW, Wetzels JF, Klasen IS, Hilbrands LB, Hoitsma AJ. ter Meulen CG, et al. Among authors: klasen is. Transplantation. 2004 Jan 27;77(2):281-6. doi: 10.1097/01.TP.0000101702.73759.F3. Transplantation. 2004. PMID: 14742994

10

[From gene to disease; the haemolytic uraemic syndrome can be caused by mutations in regulating factors of the alternative route of the complement system].

Geelen JM, Klasen IS, van den Heuvel LP, Monnens LA. Geelen JM, et al. Among authors: klasen is. Ned Tijdschr Geneeskd. 2007 Jan 20;151(3):185-8. Ned Tijdschr Geneeskd. 2007. PMID: 17288344 Review. Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page